Comments
Loading...

Inhibikase Therapeutics Earnings Estimates

IKTNASDAQ
Logo brought to you by Benzinga Data
$1.84
-0.14-6.84%
At close: -
$2.01
0.179.24%
After Hours: Apr 3, 4:42 PM EDT

Inhibikase Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:IKT | Benzinga

Inhibikase Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Apr 21
EPS Estimate
$-0.100
Quarterly Revenue Estimate
Annual Revenue
(as of Dec 31)

Analyze the earnings history of Inhibikase Therapeutics using advanced sorting and filters.

Get Alert
IKTInhibikase Therapeutics-$0.73-$0.11$0.0005/14/2025Get Alert
IKTInhibikase Therapeutics-$0.64-$0.10$1.00K04/21/2025Get Alert
IKTInhibikase Therapeutics-$0.75-$0.67-$0.652.99%$79.57K$0.0011/14/2024Get Alert
IKTInhibikase Therapeutics-$0.94-$0.67-$0.661.49%$116.41K$0.0008/14/2024Get Alert
IKTInhibikase Therapeutics-$0.96-$0.79-$0.737.59%$64.52K$0.0005/15/2024Get Alert
IKTInhibikase Therapeutics-$1.02-$0.85-$0.6424.71%$63.57K$1.00K03/27/2024Get Alert
IKTInhibikase Therapeutics-$1.08-$1.19-$0.8627.73%$7.29K$79.57K11/14/2023Get Alert
IKTInhibikase Therapeutics-$1.08-$0.92-$1.11-20.65%$6.55K$116.41K08/14/2023Get Alert
IKTInhibikase Therapeutics-$1.08-$0.84-$0.96-14.29%$46.03K$64.52K05/15/2023Get Alert
IKTInhibikase Therapeutics-$1.20-$1.14-$1.0210.53%$1.94M$63.57K03/31/2023Get Alert
IKTInhibikase Therapeutics-$1.08-$1.08-$1.080.00%$328.46K$200.00K$7.29K-96.35%11/14/2022Get Alert
IKTInhibikase Therapeutics-$1.32-$1.14-$1.085.26%$1.36M$300.00K$6.55K-97.82%08/12/2022Get Alert
IKTInhibikase Therapeutics-$1.56-$1.02-$1.08-5.88%$1.41M$300.00K$46.03K-84.66%05/16/2022Get Alert
IKTInhibikase Therapeutics-$0.90-$1.02-$1.20-17.65%$170.42K$300.00K$1.94M548.00%03/31/2022Get Alert
IKTInhibikase Therapeutics-$0.48-$0.84-$1.08-28.57%$37.68K$328.00K$328.46K0.14%11/15/2021Get Alert
IKTInhibikase Therapeutics-$0.30-$2.28-$1.3242.11%$219.59K$300.00K$1.36M354.33%08/16/2021Get Alert
IKTInhibikase Therapeutics-$0.42-$1.56$1.41M05/17/2021Get Alert
IKTInhibikase Therapeutics-$0.30-$0.90$170.42K04/01/2021Get Alert

Inhibikase Therapeutics (IKT) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32024-11-14$-0.65$-0.672.99 %
Q22024-08-14$-0.66$-0.671.49 %
Q12024-05-15$-0.73$-0.797.59 %
Q42024-03-27$-0.64$-0.8524.7 %

Inhibikase Therapeutics (IKT) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q32022-11-14$7.29K$200.00K-96.4 %
Q22022-08-12$6.55K$300.00K-97.8 %
Q12022-05-16$46.03K$300.00K-84.7 %
Q42022-03-31$1.94M$300.00K548.0 %

FAQ

Q

When is Inhibikase Therapeutics (NASDAQ:IKT) reporting earnings?

A

Inhibikase Therapeutics (IKT) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Inhibikase Therapeutics (NASDAQ:IKT)?

A

The Actual EPS was $-0.65, which beat the estimate of $-0.67.

Q

What were Inhibikase Therapeutics’s (NASDAQ:IKT) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch